Report Categories
View AllRecent Articles
View All
What Teleflex Incorporated TFX disclosed about refinancing plans Q4 2025 Profit Disappoints
MRNO Murano management details crossborder investment growth plans targeting key markets in latest quarterly earnings call
RNTX Rein Therapeutics shares drop 12 percent after Q4 2025 EPS misses analyst estimates by a massive margin
Gilead Sciences GILD Strong Shareholder Mandate Robust Pipeline and Acquisition Strategy Underpin 2026 Growth Outlook